Combination therapy: intermittent sorafenib with bevacizumab yields activity and decreased toxicity von Lee, J-M, Sarosy, G A, Annunziata, C M, Azad, N, Minasian, L, Kotz, H, Squires, J, Houston, N, Kohn, E C

Volltext

Phase I trial of micronized formulation carboxyamidotriazole in patients with refractory solid tumors: pharmacokinetics, clinical outcome, and comparison of formulations von KOHN, E. C, FIGG, W. D, SAROSY, G. A, BAUER, K. S, DAVIS, P. A, SOLTIS, M. J, THOMPKINS, A, LIOTTA, L. A, REED, E

Volltext

Dose-Intense Taxol: High Response Rate in Patients With Platinum-Resistant Recurrent Ovarian Cancer von Kohn, Elise C., Sarosy, Gisele, Bicher, Annette, Link, Charles, Christian, Michaele, Steinberg, Seth M., Rothenberg, Mace, Adamo, Debra Orvis, Davis, Patricia, Ognibene, Frederick P., Cunnion, Robert E., Reed, Eddie

Volltext

A Phase I trial of carboxyamido-triazole and paclitaxel for relapsed solid tumors: Potential efficacy of the combination and demonstration of pharmacokinetic interaction von KOHN, Elise C, REED, Eddie, GOLDSPIEL, Barry, PLUDA, James, FIGG, William D, LIOTTA, Lance A, SAROSY, Gisele A, MINASIAN, Lori, BAUER, Kenneth S, BOSTICK-BRUTON, Frieda, KULPA, Vyta, FUSE, Eichi, TOMPKINS, Anne, NOONE, Marianne

Volltext

Phase I study of taxol and granulocyte colony-stimulating factor in patients with refractory ovarian cancer von SAROSY, G, KOHN, E, STONE, D. A, ROTHENBERG, M, JACOB, J, ADAMO, D. O, OGNIBENE, F. P, CUNNION, R. E, REED, E

Volltext

Dose intensive combination platinum and cyclophosphamide in the treatment of patients with advanced untreated epithelial ovarian cancer von Shapiro, Jeremy D., Rothenberg, Mace L., Sarosy, Gisele A., Steinberg, Seth M., Adamo, Debra O., Reed, Eddie, Ozols, Robert F., Kohn, Elise C.

Volltext

The systemic administration of intravenous melphalan von G Sarosy, B Leyland-Jones, P Soochan, B D Cheson

Volltext

Phase II Trial of Carboxyamidotriazole in Patients With Relapsed Epithelial Ovarian Cancer von HUSSAIN, Mahrukh M, KOTZ, Herbert, FIGG, William D, KOHN, Elise C, MINASIAN, Lori, PREMKUMAR, Ahalya, SAROSY, Gisele, REED, Eddie, SUOPING ZHAI, STEINBERG, Seth M, RAGGIO, Miranda, OLIVER, Vyta Kulpa

Volltext

A Phase I/II Study of Dose-Intense Paclitaxel with Cisplatin and Cyclophosphamide as Initial Therapy of Poor-Prognosis Advanced-Stage Epithelial Ovarian Cancer von Kohn, Elise C., Sarosy, Gisele A., Davis, Patricia, Christian, Michaele, Link, Charles E., Ognibene, Frederick P., Sindelar, William F., Jacob, Joan, Steinberg, Seth M., Premkumar, Ahalya, Reed, Eddie

Volltext

Taxol dose intensification and its clinical implications von SAROSY, G, REED, E

Volltext

Incapacitating Autonomic Neuropathy Precipitated by Taxol von Jerian, Susan M., Sarosy, Gisele A., Link, Charles J., Fingert, Howard J., Reed, Eddie, Kohn, Elise C.

Volltext

Phase I study of dasatinib in combination with bevacizumab in advanced solid tumors von Kim, G., Annunziata, C. M., Sarosy, G. A., Minasian, L. M., Prindiville, S. A., Zujewski, J., Otten, L., Squires, J., Houston, N. D., Kohn, E. C.

Volltext

Synchronous inflammatory breast cancer and advanced ovarian carcinoma: A case with prolonged disease-free survival von Sandor, V., Reed, E., Sarosy, G., Middleton, L. P., Davis, P., Kohn, E.

Volltext

Cutaneous manifestations of taxol® therapy von LINK, C. J, SAROSY, G. A, KOHN, E. C, CHRISTIAN, M. C, DAVIS, P, ADAMO, D. O, REED, E

Volltext

Flexible granulocyte colony-stimulating factor dosing in ovarian cancer patients who receive dose-intense taxol therapy von LINK, C. J, BICHER, A, KOHN, E. C, CHRISTIAN, M. C, DAVIS, P. A, ADAMO, D. O, REED, E, SAROSY, G. A

Volltext

Increased efficacy and toxicity with combination anti-VEGF therapy using sorafenib and bevacizumab von Azad, N. S., Posadas, E. M., Kwitkowski, V. E., Annunziata, C. M., Barrett, T., Premkumar, A., Kotz, H. L., Sarosy, G. A., Minasian, L. M., Kohn, E. C.

Volltext

The absence of cumulative bone marrow toxicity in patients with recurrent adenocarcinoma of the ovary receiving dose-intense taxol and granulocyte colony stimulating factor von Bicher, Annette, Kohn, Elise, Sarosy, Gisele, Davis, Patricia, Adamo, Debra O, Jacob, Joan, Christian, Michaele, Reed, Eddie

Volltext

Clinical investigation of a cytostatic calcium influx inhibitor in patients with refractory cancers von KOHN, E. C, REED, E, LIOTTA, L. A, SAROSY, G, CHRISTIAN, M, LINK, C. J, COLE, K, FIGG, W. D, DAVIS, P. A, JACOB, J, GOLDSPIEL, B

Volltext

N-methylformamide: cytotoxic, radiosensitizer, or chemosensitizer von Clagett-Carr, K, Sarosy, G, Plowman, J, Hoth, D F, Leyland-Jones, B

Volltext

Borderline ovarian tumors von Link, Charles J., Reed, Eddie, Sarosy, Gisele, Kohn, Elise C.

Volltext